 MONMOUTH JUNCTION, N.J., Dec. 2, 2020 PRNewswire -- CytoSorbents Corporation NASDAQ: CTSO, a critical care immunotherapy leader that is commercializing its CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients around the... 